Keratinocyte Responsive Element 3: Analysis of a Keratinocyte-specific Regulatory Sequence in the 230-kDa Bullous Pemphigoid Antigen Gene Promoter  by Matsuzaki, Yasushi et al.
ORIGINAL ARTICLE
Keratinocyte Responsive Element 3: Analysis of a Keratinocyte-
speci¢c Regulatory Sequence in the 230-kDa Bullous Pemphigoid
Antigen Gene Promoter
Yasushi Matsuzaki,n KatsutoTamai, Atsushi Kon, Daisuke Sawamura, Jouni Uitto,n and Isao Hashimoto
Department of Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan; nDepartment of Dermatology and Cutaneous Biology, Je¡erson
Medical College, Philadelphia, PA, U.S.A.
The 230-kDa bullous pemphigoid antigen gene is ex-
pressed primarily, if not exclusively, in basal keratino-
cytes of the epidermis. Keratinocyte responsive
element 3, a cis-element at position ^216 to ^197 of
the human 230-kDa bullous pemphigoid antigen gene
promoter, confers tissue-speci¢c expression to this gene
(Tamai et al: J Biol Chem 270:7609^7614, 1995). In this
study, we investigated the functional characteristics of
keratinocyte responsive element 3 on the 230-kDa
bullous pemphigoid antigen gene core promoter by
transient transfections of cultured normal human kera-
tinocytes and normal human ¢broblasts, as well as of
lung carcinoma (A549), osteosarcoma (OST), and gas-
tric adenocarcinoma (GT3TKB) cell lines. A 230-kDa
bullous pemphigoid antigen gene core promoter/luci-
ferase reporter gene plasmid construct, pBPL, was
modi¢ed to develop a series of constructs (pKBPL^
p4KBPL), which have insertions of one, two, three, or
four tandem repeats of keratinocyte responsive element
3, and these plasmids were used in transient transfec-
tions of the cultured cells. The promoter activities of
pKBPL^p4KBPL constructs, relative to pBPL, in nor-
mal human keratinocytes were 7.6-, 15.5-, 4.6-, and 2.7-
fold higher, respectively, whereas no upregulatory e¡ect
by keratinocyte responsive element 3 insertion was ob-
served in other cell lines tested. prKBPL, a plasmid
constructed with keratinocyte responsive element 3 in
reverse orientation, showed essentially no activity in
normal human keratinocytes. Insertion of a random 20
bp sequence between keratinocyte responsive element 3
and the 230-kDa bullous pemphigoid antigen gene core
promoter resulted in about 40% reduction of luciferase
activity in normal human keratinocytes. These data
suggest that keratinocyte responsive element 3 func-
tions as a position-, copy number-, and orientation-
dependent cis-element contributing to tissue-speci¢c
regulation of the 230-kDa bullous pemphigoid antigen
gene. Key words: Bullous pemphigoid antigens/keratinocyte
gene expression/transcriptional regulation. J Invest Dermatol
120:308 ^312, 2003
B
ullous pemphigoid (BP) is a cutaneous blistering
disease characterized by the presence of circulating
IgG autoantibodies in the patients’ sera (Lever, 1965;
Stanley et al, 1981). Western blot analyses of BP
patients’ sera have recognized at least two distinct pro-
teins that are associated with epidermal keratinocytes, so-called
bullous pemphigoid antigens (BPAGS), which serve as autoanti-
gens in the disease. The major antigen recognized in most pa-
tients’ sera is a 230-kDa protein, designated as BPAG1, whereas
another protein, BPAG2, recognized in relatively few patients’
sera, has a molecular weight of 180-kDa (Mueller et al, 1989;
Meyer et al, 1990; Sawamura et al, 1992). Immunoelectron micro-
scopic studies have indicated that these two autoantigens are asso-
ciated with hemidesmosomes, attachment complexes spanning
from the intracellular milieu of the basal keratinocytes to the un-
derlying lamina lucida (Westgate et al, 1985; Mutasim et al, 1985).
cDNA cloning and chromosomal mapping of the BP antigen
genes have clearly demonstrated that BPAG1 and BPAG2 are dis-
tinct gene products (Sawamura et al, 1992). Speci¢cally, cloning of
the BPAG1 cDNA has demonstrated that the 230-kDa protein is
a noncollagenous component of the intracellular hemidesmoso-
mal plaque (Sawamura et al, 1991a,b;Tanaka et al, 1991). In contrast,
the 180-kDa BP antigen is a transmembrane collagenous protein
(Giudice et al, 1991, 1992; Hopkinson et al, 1992; Li et al, 1992),
designated as type XVII collagen (Li et al, 1993). In addition
to cDNA cloning, the entire gene structure and the intron^exon
organization of the human BPAG1 gene have been delineated
(Tamai et al, 1993).This gene has been shown to consist of 22 distinct
exons spanningB20 kb of the genomic DNA in the short arm of
human chromosome 6 (Sawamura et al, 1990;Tamai et al, 1993).
The expression of the BPAG1 gene in the skin, as determined
at the mRNA level, has been shown to be limited to keratino-
cytes with proliferative, basal keratinocyte-like phenotype
(Arnemann et al, 1993). The speci¢city of the expression of this
gene has also been demonstrated by transient transfection studies
utilizing the BPAG1 gene promoter/chloramphenicol acetyltrans-
ferase reporter gene constructs in various cell types (Tamai et al,
1993). Subsequently, a speci¢c cis-regulatory element, designated
as keratinocyte responsive element (KRE) 2, has been identi¢ed
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at position ^1786 to ^1778 (upstream from the transcription
initiation site) within the BPAG1 promoter (Tamai et al, 1993,
1994). KRE2 was shown to have AP2 binding activity, whereas
keratinocyte nuclear extract also had another KRE2-binding
protein, designated as a KTP-1 (Tamai et al, 1994). Elimination
of KRE2 sequence from the BPAG1 promoter resulted in ap-
proximately 60% reduction in its activity in keratinocytes (Tamai
et al, 1993). Subsequent studies revealed a novel cis-element,
KRE3, at position ^216 to ^197 of the human BPAG1 gene pro-
moter (Tamai et al, 1995a). A BPAG1 promoter/chloramphenicol
acetyltransferase construct containing KRE3 had up toB50-fold
higher expression than a similar construct devoid of this sequence
when tested in transient transfections of cultured human kerati-
nocytes. Thus, KRE3 was postulated to confer keratinocyte-spe-
ci¢c expression to the BPAG1 gene (Tamai et al, 1995a).
In this study, we examined the functional characteristics of
KRE3 to determine the speci¢city of its position with regard to
the BPAG1 core promoter, its copy number requirements, and or-
ientation responsible for conferring tissue-speci¢c regulation of
the expression of the BPAG1 gene.
MATERIALS AND METHODS
Plasmid constructs The human BPAG1 core promoter region,
extending from position ^1 to ^196 counting upstream from the
transcription initiation site was inserted in front of the luciferase gene of a
plasmid pGEM-luc (Promega, Madison, WI), designated as pBPL
construct, being devoid of the KRE3 element (50 -GTGCAAATATTT-
GGCATATC-30). As a control, the herpes simplex virus thymidine kinase
(TK) promoter, position ^1 to ^722, was also inserted to pGEM-luc, a
construct designated pTKL. Plasmids pKBPL, p2KBPL, p3KBPL, and
p4KBPL were constructed by insertion of one, two, three, or four tandem
repeats of the KRE3 sequence, respectively, at position ^196 of the BPAG1
promoter in pBPL plasmid. Similarly, pKTKL, p2KTKL, and p3KTKL
were constructed by insertion of one, two, or three KRE3 repeats in
front of the TK promoter. pKins20BPL was constructed by insertion of a
random 20 bp sequence at ^196 of the BPAG1 promoter in pKBPL.
Reverse KRE3 sequence (50 -CTATACGGTTTATAAACGTG-30) was
inserted at ^196 of the BPAG1 promoter in pBPL, and this construct was
referred as prKBPL. All constructs were sequenced in both directions to
con¢rm their nucleotide sequence.
Cell cultures Normal human epidermal keratinocytes (NHK), which
were obtained from Clonetics (San Diego, CA), were maintained in
serum-free, low calcium (0.15 mM) keratinocyte growth medium
supplemented with epidermal growth factor, hydrocortisone, insulin, and
bovine pituitary extract (Clonetics). The cell cultures were treated by
trypsinization and studied at passage 3. Normal human ¢broblasts (NHF)
were established from human biopsy specimens, and the human lung
carcinoma cell line A549, the human osteosarcoma cell line OST, and the
human gastric adenocarcinoma cell line GT3TKB were obtained from
RIKEN Cell Bank (Tsukuba, Japan). These cultures were maintained in
Dulbecco’s modi¢ed Eagle’s medium supplemented with 10% fetal bovine
serum, 2 mM glutamine, 50 mg streptomycin per ml, and 50 units penicillin
per ml.
Transient cell transfections The series of plasmid constructs described
above were used for transient transfection studies in NHK, NHF, A549,
OST, and GT3TKB cultures. These cells were also transfected with a
cytomegalovirus promoter/luciferase reporter gene plasmid construct
(pCMVL) and the luciferase reporter gene plasmid (pGEM-luc), which
were used as positive and negative controls, respectively, of transfection
e⁄ciencies. In each experiment, cultured cells were transfected in 60 mm
diameter dish when 70^80% con£uent. All transfections were performed
with commercial kit (DOTAP, Roche Diagnostics, Mannheim,
Germany). After 24 h of transfection, the cell cultures were placed in fresh
culture medium and grown for an additional 24 h prior to harvesting.
Luciferase assay Cultured cells were washed twice with phosphate-
bu¡ered saline and scraped into 250 ml of cell culture lysis reagent LCb/
PGC-51 (Toyo Ink, Tokyo, Japan). Insoluble protein was removed by a 2
min centrifugation at 15,000 g and the supernatant was immediately
assayed for luciferase activity using commercial kit (Picagene, Toyo Ink).
In the assay, 20 ml of cell extract and 100 ml of luciferin mixture were
reacted for 5 s and light output was monitored over the next 10 s. All
assays were performed in triplicate, and each experiment was repeated a
minimum of three times. Each luciferase activity value was corrected for
protein amount in each sample. The values were expressed as mean7SD,
and the statistical signi¢cance of di¡erences between treatment groups was
calculated by Student’s two-tailed t-test.
RESULTS
Enhancement of BPAG1 promoter activity by KR3 is copy
number dependent Previous studies have demonstrated that
the BPAG1 gene is speci¢cally expressed in epidermal
keratinocytes (Stanley, 1989; Tamai et al, 1993), and KRE3 was
suggested to confer tissue-speci¢c expression to the BPAG1 gene
(Tamai et al, 1995a). In this study, we examined the KRE3
functional characteristics, ¢rst by inserting various numbers of
KRE3 in front of the human BPAG1 core promoter. In transient
transfection studies in NHK, the relative promoter activities of
pKBPL, p2KBPL, p3KBPL, and p4KBPL were 7.6-, 15.5-, 4.6-,
and 2.7-fold higher, respectively, in comparison with pBPL
(Fig 1). The highest promoter activity was obtained by insertion
of two tandem repeats of KRE3. Addition of further repeats of
KRE3, however, resulted in lower promoter activities as
compared with one or two repeats, suggesting the importance of
relative position of KRE3 elements toward the core promoter of
BPAG1.
Sense orientation of KRE3 is critical for the enhancement of
BPAG1 promoter activity in NHK To investigate whether
the orientation of KRE3 has an e¡ect on its cis-regulatory
activity, prKBPL containing the KRE3 sequence in reverse
orientation in front of the BPAG1 core promoter was
constructed, transfected in NHK, and the promoter activity was
compared with the activities of pBPL and pKBPL. As shown in
Fig 2, prKBPL resulted in essentially no luciferase activity, which
was even less than that noted with pBPL. In the same experiment
Figure1. E¡ect of KRE3 on the BPAG1 core promoter activity in
cultured NHK. The plasmid pBPL was constructed by insertion of the
BPAG1 core promoter at the 50 end of the luciferase gene ( LUC ) in
the plasmid pGEM-luc. Plasmids pKBPL, p2KBPL, p3KBPL, and
p4KBPL contain one, two, three, or four tandem repeats of KRE3 se-
quence , respectively, at position ^196 upstream from the transcription
initiation site of the BPAG1 promoter in the pBPL plasmid.These con-
structs were transiently transfected to cultured NHK, and the promoter
activities of each construct were expressed as luciferase activity . The
relative luciferase activity with KRE3 containing constructs was expressed
in relation to pBPL which was set at 100. The values are expressed as mean
7 SD from three parallel samples in three to four separate experiments,
after correction of the activity for the amount of protein in the same cell
extracts. The signi¢cance of di¡erences, in relation to pBPL construct, is
indicated by asterisks (npo0.01, nnpo0.001).
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pKBPL resulted inB7-fold enhancement of luciferase activity in
comparison with pBPL. These data suggest that the spatial
orientation of KRE3 is crucial for optimal transcriptional
regulation on the BPAG1 promoter.
The relative position of KRE3 in relation to BPAG1 core
promoter in£uences the activity in NHK To determine
whether the relative position of KRE3 with respect to the
BPAG1 core promoter has an e¡ect on its activity, the
pKins20BPL construct, which has an insertion of a random 20
bp sequence between the KRE3 sequence and the BPAG1 core
promoter in pKBPL was tested in NHK cultures. Insertion of
the 20 bp sequence in this construct places the KRE3 sequence
to correspond to the upstream KRE3 repeat in p2KBPL. The
construct pKins20BPL was then compared with pBPL, pKBPL,
and p2KBPL for the promoter activity by luciferase assay. As
shown in Fig 3, promoter activity of pKins20BPL was
approximately 60% lower than that of pKBPL, although it was
still higher than that of pBPL. These data indicate that the
relative position of KRE3 relative to the core promoter is
important for its optimal activity.
The KRE3 element displays cell type speci¢c regulatory
e¡ects Previous studies have suggested that KRE3 has a
transcriptional regulatory function in the BPAG1 promoter in
NHK, but not in NHF (Tamai et al, 1995a). To explore further
the cell type speci¢city of the KRE3 function, the plasmids
pBPL, pKBPL, and p2KBPL were transiently transfected in
NHK, NHF, A549, OST, and GT3TKB cell lines, and the
impact of the presence of KRE3 was evaluated by luciferase
assay. The pCMVL plasmid was also transfected in these cell
lines to verify transfection e⁄ciencies. The relative promoter
activities of pKBPL and p2KBPL, in comparison with pBPL,
were signi¢cantly higher in NHK, whereas in OST and
GT3TKB cell lines KRE3 had minimal e¡ects on the BPAG1
promoter activity (Fig 4). Furthermore, the BPAG1 promoter
activities were not detectable in NHF and A549 (Table I). These
data clearly suggest that KRE3 functions as a tissue-speci¢c
transcriptional regulatory sequence in the BPAG1 gene.
E¡ects of KRE3 on heterologous TK promoter activity in
NHK To determine whether the KRE3 element can in£uence
heterologous promoter activity, we tested the e¡ect of KRE3
insertion on the herpes simplex virus-TK promoter. As shown
in Fig 5, one or two KRE3 insertions upstream to the TK in
the pKTKL and p2KTKL promoter constructs did not confer
any enhancement on the TK promoter activity in luciferase
assay, whereas p3KTKL, containing a three KRE3 repeats
insertion, resulted in a strong suppression of the TK promoter
activity. This study suggested that KRE3 could have an e¡ect on
the heterologous promoter activity, but in a di¡erent manner, as
compared with those e¡ects observed in the BPAG1promoter.We
cannot, however, rigorously exclude the possibility that the
di¡erent position of KRE3 in pKBPL and in pKTKL constructs
(^196 and ^722 with respect to transcription initiation sites) may
explain the di¡erent results with these two constructs.
Figure 2. E¡ect of KRE3 orientation on the BPAG1 promoter
activity in cultured NHK. The plasmid prKBPL was constructed by
insertion of KRE3 reverse sequence (50 -CTATACGGTTTATAAACGTG-
30) at the 50 end of the BPAG1 core promoter in pBPL, and subjected
to transient transfection to cultured NHK together with pBPL and pKBPL;
the latter construct contains the KRE3 sequence in sense orientation. Note
that prKBPL has very low promoter activity in NHK. The values are ex-
pressed as in Fig 1. The signi¢cance of di¡erences is indicated by an asterisk
(nnpo0.001).
Figure 3. The positional e¡ect of KRE3 on the BPAG1 promoter
activity in cultured NHK. The plasmid pKins20BPL was constructed
by insertion of a random 20 bp sequence between the KRE3 and the
core promoter of BPAG1 in pKBPL. The promoter activity in cultured
NHKwas compared with those noted with pBPL, pKBPL, and p2KBPL,
as determined by luciferase assay. About 60% lower promoter activity was
obtained by pKins20BPL as compared with the activity of pKBPL. Signif-
icance of di¡erences is indicated by an asterisk (npo0.01).
Figure 4. Cell-type speci¢c e¡ect of KRE3 on the BPAG1 core pro-
moter activity in various cell lines. The plasmids pBPL, pKBPL, and
p2KBPL were transiently transfected in NHK, NHF, A549, OST, and
GT3TKB cell cultures, and the role of KRE3 was evaluated by luciferase
assay in each cell type (seeTable I). The values are expressed as the relative
luciferase activity of pKBPL and p2KBPL, in relation to pBPL (set as 1.0),
in NHK, OST, and GT3TKB, in which signi¢cant luciferase activities of
the BPAG1 promoter plasmid constructs were obtained. No detectable ac-
tivity was noted in NHF and A549 cells (see Table I). Note that KRE3
dramatically increased the BPAG1 promoter activities in NHK, but not in
OST and GT3TKB cultures. Signi¢cant di¡erence is indicated by asterisks
(nnpo0.001).
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DISCUSSION
BPAG1 is an intracellular component of hemidesmosomes,
attachment complexes anchoring epidermal basal keratinocytes
to the underlying basement membrane. Expression of the BPAG1
gene is restricted to strati¢ed squamous epithelia, including
epidermal keratinocytes, and its expression is regulated, at least
in part, at the level of transcription. Previous studies on the
BPAG1 gene promoter have reported the existence of several
cis-regulatory elements controlling tissue-speci¢c expression,
such as KRE2 and KRE3 (Tamai et al, 1994, 1995a,b). Subsequent
studies suggested that KRE3, a 20 bp cis-regulatory element ex-
tending from position ^216 to ^197 of the BPAG1 promoter, is
necessary for epidermal-speci¢c expression of this gene.
In this study, the functional characteristics of KRE3 were
examined, and its copy number, relative position, and spatial or-
ientation were shown to a¡ect its activity as a tissue-speci¢c reg-
ulatory element. Those functions were speci¢c to epidermal
keratinocytes among the cell lines so far examined, and di¡erent
KRE3 activities were observed on a heterologous promoter, as
exempli¢ed by the TK gene promoter, which KRE3 can down-
regulate if inserted in the form of three tandem repeats. In this
context, it is of interest that KRE3 when present in one or two
copies had minimal e¡ect on TK promoter, whereas addition of
the third copy in p3KTKL markedly reduced the promoter activ-
ity. A reduction in the BPAG1 core promoter activity was also
noted when the third and fourth copy of KRE3 were added to
the constructs p3KBPL and p4KBPL, respectively.These observa-
tions further emphasize the position-dependent nature of the
e¡ect of KRE3 on the promoter activity.
Characteristic palindromic sequence, 50 -CAAATATTTG-30,
was identi¢ed embedded within the KRE3 element (Tamai et al,
1995a), and palindromic structures are generally observed in cis-
regulatory elements such as cognate AP1 and AP2 sequences.
It should be noted, however, that this palindromic structure is
surrounded by nonpalindromic sequences in the 20 bp KRE3
sequence inserted in front of the BPAG1 core promoter. The pre-
sence of nonpalindromic sequences may explain the orientation-
dependent e¡ect of KRE3, as it in anti-sense orientation elicited
no enhancement of the BPAG1 promoter activity. This possibility
is emphasized by previous demonstrations that 2 bp nucleotide
substitutions both within the palindromic core as well £anking
nonpalindromic sequences result in reduced promoter activity of
BPAG1 (Tamai et al, 1995a). Previous studies indicated the exis-
tence of speci¢c KRE3 binding nuclear proteins in keratinocytes,
but not in ¢broblasts (Tamai et al, 1995a), suggesting that there is a
keratinocyte-speci¢c, KRE3-dependent transcriptional regula-
tory system conferring tissue-speci¢c expression to the BPAG1
gene. Other studies on the mouse BPAG1 promoter have de¢ned
an active region for tissue speci¢c expression of the gene to reside
between ^525 and ^213 of the 50 £anking DNA (Sawamura et al,
1994), and this region also contains a KRE3-like sequence be-
tween ^283 and ^264. Recent studies have also demonstrated that
homeodomain proteins, Engrailed and Antennapedia, upregulate
transcription of the BPAG1 gene through their DNA binding
activities of homeodomain regions, EnHD and AntpHD, respec-
tively (Mainguy et al, 1999). EnHD and AntpHD, however, were
shown to recognize sequences clearly di¡erent from KRE3,
suggesting that tissue speci¢city of BPAG1 is regulated, at
least in part, by nuclear proteins that are di¡erent in Engrailed
and Antennapedia.
Dissection of the regulatory elements responsible for expres-
sion of various epidermal genes has revealed distinct cis-regula-
tory regions in di¡erent genes with the capacity to switch the
genes on or o¡ (Eckert et al, 1997). For example, recent studies
on the human involucrin gene have identi¢ed the distal regula-
tory region as crucial for epidermal expression of the correspond-
ing gene and shown it to reside between ^2473 and ^2088
in the 50 £anking DNA (Welter et al, 1995). Further studies
indicated involvement of Sp1 and AP1 in the distal regulatory
region system, and AP1 was shown to function as the on/o¡
switch for the gene expression (Banks et al, 1998). Other studies
on the human SPRR3 gene promoter have shown the ex-
istence of functional AP1, Ets, and ATF/CRE binding sites
in the core promoter region and have suggested cooperative
regulation of these elements for tissue-speci¢c transcription of
the gene (Fischer et al, 1999). Most of the transcriptional systems
involved in the epidermal gene regulation are shared with other
tissues for their speci¢c gene regulation, suggesting that the pat-
terns of combination of various transcriptional factors might de-
¢ne tissue-speci¢c expression of each gene. In the BPAG1
promoter region, putative CCAAT and Sp1 motifs were identi-
¢ed just downstream of the KRE3 sequence (Tamai et al, 1995a).
The observations on the position- and orientation-dependent ef-
fects of KRE3 on BPAG1 core promoter activity might suggest
cooperation with other cis-regulatory elements, including
CCAAT and Sp1 motifs, for epidermal-speci¢c expression of the
gene.
Table I. Expression of the BPAG1 Core Promoter Constructs inVarious Cell Cultures, and Cell-Type Speci¢c E¡ects of KRE3
Cell cultures: NHK NHF A549 OST GT3TKB
Luciferase Activity (arbitrary chemiluminescence units)n
pBPL (3.670.7) 102 ND ND (2.170.3) 102 (1.870.3) 102
pKBPL (2.570.2) 103 ND ND (3.570.7) 102 (1.470.8) 102
p2KBPL (5.172.4) 103 ND ND (3.570.7) 102 (1.870.2) 102
pCMVL (7.471.6) 106 (2.670.3) 105 (3.870.4) 105 (1.170.2) 105 (1.170.1) 105
nThe values are expressed as mean7SD of triplicate cultures transfected in parallel.
ND: Not detected
Figure 5. E¡ect of KRE3 on the TK promoter activity in cultured
NHK. The plasmid pTKL has the TK promoter in front of the luci-
ferase gene in the plasmid pGEM-luc. Plasmids pKTKL, p2KTKL, and
p3KTKL were constructed by insertion of one, two, or three tandem re-
peats of KRE3 sequence at position ^722 from the transcription initiation
site of theTK promoter in the pTKL plasmid. These constructs were trans-
fected to cultured NHK, and the promoter activity was determined by lu-
ciferase assay. Note that one or two KRE3 repeat insertions did not
signi¢cantly a¡ect the TK promoter activity, but p3KTKL, containing
three KRE3 repeats, showed strong suppression of TK promoter activity
in NHK. Signi¢cance of di¡erences is indicated by asterisks (nnpo0.001).
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In summary, we have de¢ned several functional characteristics
of KRE3, an upregulatory cis-element in the BPAG1 promoter.
Information on the KRE3 function increases our understanding
of the keratinocyte-speci¢c expression of genes and also provides
a potential pharmacologic perspective to enhance the expression
of genes in the epidermis.
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